SEC Form 4 · accession 0000886163-15-000066
LIGAND PHARMACEUTICALS INC · LGND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Kozarich
Director
Period of report
May 15, 2015
Accepted (ET)
May 18, 2015 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000886163
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 15, 2015 | G | 500 | — | D | 49,711 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Charitable gift to a third party.